Biotech M&A With a Quick Start in 2023!
Is There Any Chance to Beat 2022 Numbers ?
| Date | Acquirer Co. | Acquirer Ticker | Acquired Co. | Acquired Ticker | Deal value | Price/Share | Notes | Link to the news PR |
|---|---|---|---|---|---|---|---|---|
| 01/04/2023 | Moderna | MRNA | OriCiro Genomics | Private- Japan | $85M | - | Cynthetic biology and enzyme technologies | https://bit.ly/3IinwVP |
| 01/09/2023 | Chiesi Farmaceutici | Private | Amryt Pharma | AMYT | $1.25B | $14.50 | $2.5 CVR total $225M | https://bit.ly/3k62nnS |
| 01/09/2023 | IPSEN - France | IPSEY | Albireo | ALBO | $952 | $42.00 | $10 CVR | https://bwnews.pr/3QmQrtX |
| 01/09/2023 | Astra | AZN | CinCor Pharma | CINC | $1.3B | $26.00 | $10 CVR | https://bit.ly/3incbsT |
| 01/17/2023 | Shockwave Medical | SWAV | Neovasc | NVCN | $100M | $27.25 | minimally invasive treatment of refractory angina. | https://bit.ly/3H8luXc |
| 01/19/2023 | Sun Pharma | Indian Co. | Concert Pharmaceuticals | CNCE | $576M | $8.00 | $3.5 CVR Oral JAK Inhibitor for the Treatment of Alopecia Areata | https://bwnews.pr/3CZVmvr |
For M&A 2022 full table click here https://www.chimeraresearchgroup.com/biotech-ma-2022-deals/
